The post Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge appeared first on StartupHub.ai.

Adaptam Therapeutics has raised €3 million in Adaptam Therapeutics funding to advance novel antibody-based cancer immunotherapies that disarm the tumor’s immune-suppressing defenses.

The post Adaptam Therapeutics Funding Targets Tough Cancer Immunotherapy Challenge appeared first on StartupHub.ai.